| | Prognostic factors | 5-year overall survival (%) | value |
| | Age | | 0.17 | | 50 years | 93 | | | 50 years | 78.6 | | | Stage | | 0.4 | | II | 77 | | | III–IV | 53.3 | | | Histological type | | 0.6 | | Serous | 68.7 | | | Mucinous | 75 | | | Other | 92 | | | Histological grade | | 0.002 | | Grade I | 85 | | | Grades II-III | 33.2 | | | Initial tumoral residuum | | 0.017 | | Null | 64.4 | | | 1 cm | 0 | | | 1 cm | 61 | | | Second look | | 0.031 | | Negative | 90 | | | Positive | 77.6 | | | Lymphadenectomy at SLL | | 0.067 | | yes | 84.1 | | | No | 76.9 | | | Residuum at SLL | | 0.003 | | Null | 76 | | | Microscopic | 72 | | | Macroscopic | 30.7 | |
|
|